AGA GUIDELINES Bundle (free trial)

Crohn's Disease

AGA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/784440

Contents of this Issue

Navigation

Page 6 of 7

Disease Figure 6 (cont'd) Perform treatment for patient not in remission Low-risk patient G Mod/high-risk patient I Options: • Immunosuppressive • Assess drug levels • Consider anti-TNF therapy Options: • Use anti-TNF monotherapy over no therapy or thiopurine monotherapy • Use anti-TNF + thiopurine over thiopurine monotherapy or anti-TNF monotherapy Positive response Failure to respond Low or undetectable drug concentration and low or undetectable anti-drug Low or undetectable drug concentration and high anti-drug antibody Therapeutic drug concentration and low or undetectable anti-drug antibody Increase drug dose Switch within drug class Assess inflammation Inflammation present Inflammation not present Switch to another drug class Continue drug at current dose and look for other causes

Articles in this issue

Archives of this issue

view archives of AGA GUIDELINES Bundle (free trial) - Crohn's Disease